Wendy Cross

Wendy is a CMC Matrix Leader at GSK, where she is responsible for leading oligonucleotide projects through late phase development and into commercialisation.  Prior to taking this role, Wendy worked in a variety of technical roles where her main responsibility was the development of robust crystallisation processes for a broad range of small molecules at all phases of development.  She holds a PhD in inorganic chemistry/X-ray crystallography from the University of Manchester.